Holding(s) in Company

Summary by AI BETAClose X

UBS Group AG, through UBS AG, has acquired a significant stake in Renalytix PLC, increasing its voting rights from 5.089787% to 7.442592%, representing 32,525,518 voting rights. This notification, dated December 16, 2025, follows an acquisition of voting rights that occurred on December 12, 2025, with no financial instruments involved in this change.

Disclaimer*

UK 100

Latest directors dealings